Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TARS Tarsus Pharmaceuticals, Inc.

盘前交易 05-21 05:05:05 EDT

38.73

+0.49

+1.28%

最高39.48	最低37.86	成交量62.43万
今开38.32	昨收38.24	日振幅4.25%
总市值14.63亿	流通市值9.24亿	总股本3,778万
成交额2,418万	换手率2.62%	流通股本2,386万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TARS","market":"US","secType":"STK","nameCN":"Tarsus Pharmaceuticals, Inc.","latestPrice":38.73,"timestamp":1716235200000,"preClose":38.24,"halted":0,"volume":624349,"delay":0,"floatShares":23860971,"shares":37781693,"eps":-4.701497,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.49,"latestTime":"05-21 05:05:05 EDT","open":38.32,"high":39.48,"low":37.855,"amount":24176849.261257,"amplitude":0.042495,"askPrice":40.8,"askSize":13,"bidPrice":28.51,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-4.701497,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716298200000},"adr":0,"listingDate":1602820800000,"adjPreClose":38.73,"postHourTrading":{"tag":"盘后","latestPrice":38.73,"preClose":38.73,"latestTime":"17:45 EDT","volume":233435,"amount":9040938.65,"timestamp":1716241552269},"volumeRatio":1.2321002461172028},"requestUrl":"/m/hq/s/TARS","defaultTab":"news","newsList":[{"id":"2436945182","title":"Tarsus Pharmaceuticals, Inc.2024财年第一财季实现净利润-35.73百万美元，同比减少52.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436945182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436945182?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:19","pubTimestamp":1715962760,"startTime":"0","endTime":"0","summary":"3月31日，Tarsus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-35.73百万美元，同比减少52.56%；其中营业收入为27.61百万美元，同比增加1004.40%，每股基本收益为-1.01美元。从资产负债表来看，Tarsus Pharmaceuticals, Inc.总负债74.07百万美元，其中短期债务585000.00美元，资产负债比为0.05，流动比率为0.09。机构评级：截至2024年3月31日，当前有9家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为56.11美元，其中最低目标价为34.00美元，最高目标价为67.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240518001924877509f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240518001924877509f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435555820","title":"A项目TARS Protocol宣布入选Google创业计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2435555820","media":"老虎证券","top":-1,"share":"https://www.laohu8.com/m/news/2435555820?lang=zh_cn&edition=full","pubTime":"2024-05-14 12:24","pubTimestamp":1715660649,"startTime":"0","endTime":"0","summary":"【A项目TARS Protocol宣布入选Google创业计划】金色财经报道，Web3人工智能和一站式BaaS服务解决方案TARS Protocol宣布已被纳入Google 创业计划，使其能够得到人工智能行业领先开发人员的指导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514123245876640c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514123245876640c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435374216","title":"HC Wainwright & Co.：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由57.00美元调整至61.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435374216","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435374216?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:16","pubTimestamp":1715613363,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由57.00美元调整至61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132316068762ce76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132316068762ce76&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434868688","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.01%报35.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434868688","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434868688?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:51","pubTimestamp":1715352678,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时51分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报35.75美元/股，成交量19.6217万股，换手率0.52%，振幅4.52%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。该信息摘要如下：奥本海默：维持Tarsus Pharmaceuticals评级，由优于大市调整至优于大市评级, 目标价由59.00美元调整至61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022511987e87247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022511987e87247&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434604899","title":"奥本海默：维持Tarsus Pharmaceuticals(TARS.US)评级，由优于大市调整至优于大市评级, 目标价由59.00美元调整至61.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434604899","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434604899?lang=zh_cn&edition=full","pubTime":"2024-05-10 01:04","pubTimestamp":1715274289,"startTime":"0","endTime":"0","summary":"奥本海默：维持Tarsus Pharmaceuticals(TARS.US)评级，由优于大市调整至优于大市评级, 目标价由59.00美元调整至61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100104508aed9663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100104508aed9663&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433262139","title":"Tarsus Pharmaceuticals Inc   预计每股亏损1.20美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433262139","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433262139?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:01","pubTimestamp":1715047296,"startTime":"0","endTime":"0","summary":"   * Tarsus Pharmaceuticals Inc    预计将在5月8日公布截至2024年3月31日的季度收入报告。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州尔湾市的公司的营收将从去年同期的250万美元增长613.0%，达到1782.6万美元。* LSEG 分析师对 Tarsus Pharmaceuticals Inc 的平均预期是每股亏损 1.20 美元。* 华尔街对 Tarsus Pharmaceuticals Inc 的 12 个月目标价中位数为 58.00 美元，高于其上次收盘价 37.03 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432939888","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.05%报34.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432939888","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432939888?lang=zh_cn&edition=full","pubTime":"2024-05-03 02:06","pubTimestamp":1714673208,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日02时06分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.05%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Sensei Biotherapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4520.48%、690.33%、154.80%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为163.50%、78.82%、49.56%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050302064987e85602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050302064987e85602&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432863585","title":"Tarsus Pharmaceuticals, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432863585","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432863585?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:00","pubTimestamp":1714590027,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时00分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.01%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.35%。其相关个股中，Cytomx Therapeutics, Inc.、Bioatla, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1414.40%、1218.32%、267.25%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203002787e853b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203002787e853b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417781874","title":"美国研究综述-Highpeak Energy、Nordstrom、Victoria'S Secret & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2417781874","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417781874?lang=zh_cn&edition=full","pubTime":"2024-03-07 14:49","pubTimestamp":1709794169,"startTime":"0","endTime":"0","summary":"    路透社3月7日 - 华尔街证券分析师周四修改了对几家美国上市公司的评级和目标价，其中包括 Highpeak Energy、Nordstrom 和 Victoria'S Secret & Co。公司要闻             * Highpeak Energy Inc   ：Gerdes Energy Research将其评级从买入下调至卖出             * Nordstrom Inc   ：杰富瑞将其评级从买入下调至持有             * 维多利亚的秘密   ：摩根大通将其股票评级从 \"中性 \"下调至 \"减持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tarsusrx.com","stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.1939},{"period":"3month","weight":0.2732},{"period":"6month","weight":1.2056},{"period":"1year","weight":1.3967},{"period":"ytd","weight":0.9126}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tarsus Pharmaceuticals, Inc.是根据特拉华州法律于2016年11月成立的公司。该公司是一家处于临床后期的生物制药公司，致力于治疗性候选药物的开发和商业化，以解决最初存在眼科疾病的巨大市场机遇有限的治疗选择。该公司的主要产品候选产品TP-03是2b/3期的新型疗法，目前正在开发中，用于治疗由蠕形螨引起的眼睑炎，这被称为蠕形螨眼。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.056097},{"month":2,"riseRate":0.25,"avgChangeRate":0.056479},{"month":3,"riseRate":0,"avgChangeRate":-0.098569},{"month":4,"riseRate":0.5,"avgChangeRate":0.023334},{"month":5,"riseRate":0.75,"avgChangeRate":0.047627},{"month":6,"riseRate":0.666667,"avgChangeRate":0.003457},{"month":7,"riseRate":0.666667,"avgChangeRate":0.00854},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.00212},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.019603},{"month":10,"riseRate":0.666667,"avgChangeRate":0.055151},{"month":11,"riseRate":0.5,"avgChangeRate":0.053527},{"month":12,"riseRate":0.5,"avgChangeRate":0.163245}],"exchange":"NASDAQ","name":"Tarsus Pharmaceuticals, Inc.","nameEN":"Tarsus Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tarsus Pharmaceuticals, Inc.,TARS,Tarsus Pharmaceuticals, Inc.股票,Tarsus Pharmaceuticals, Inc.股票老虎,Tarsus Pharmaceuticals, Inc.股票老虎国际,Tarsus Pharmaceuticals, Inc.行情,Tarsus Pharmaceuticals, Inc.股票行情,Tarsus Pharmaceuticals, Inc.股价,Tarsus Pharmaceuticals, Inc.股市,Tarsus Pharmaceuticals, Inc.股票价格,Tarsus Pharmaceuticals, Inc.股票交易,Tarsus Pharmaceuticals, Inc.股票购买,Tarsus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}